Thermal Printer Paper from Promega
...man, Assay, 96 wells. ELISA.Specific for total MM...ed MMP-3. No cross-reactivity with MMP-1, -2, -9. ...table for use with cell culture supernatant, serum...t -15 to -30 C. Category: Drug Screening & Cellul...
Dr. P Set - Human Fetal Normal Tissue: Umbilical Cord from BioChain
Rabbit Anti-Human INHBB Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products:(Date:12/1/2009)..., Congruent Software agre...(including project accounting clients) to Synergy ... Seattle, WA (PRWEB) Decem...d today it has acquired the Microsoft Dynamics SL ...iness technology provider. The move was necessary ...
(Date:12/1/2009)..., , SAN DIEGO, Dec. 1 /PRNewswir...n Board: AEMD) announced today that it will presen... 3, 2009 at 2:00 p.m. (PST) at the Luxe Hotel in L...mes A. Joyce, will present a corporate overview an... progress for its lead product, the Hemopurifier...
(Date:12/1/2009)..., , INDIANAPOLIS and NORTH VANCOUVER, Br...ow AgroSciences LLC, a wholly owned subsidiary of ...oma Biosciences, Inc. today announced the signing ...ent. The agreement provides Dow AgroSciences with ...Loci (ETL) technology on an exclusive basis in maj...
(Date:12/1/2009)..., , SAN FRANCISCO, Dec. 1 /PRNewswire-Fi...etin Board: MZEI) announced today that in tests in..., it continues to break "6 log" decontamination ba...rming bacteria, Claustridium difficile and Bacilli...cSure(TM) as an extremely potent sporicidal techno...
Breaking Biology Technology:Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2